Latest Articles

Publication Date
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com

GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com

Published: Dec. 16, 2024, 5:30 p.m.
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis - Frontiers

Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis Frontiers

Published: Dec. 16, 2024, 4:23 p.m.
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer - OncLive

Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer OncLive

Published: Dec. 16, 2024, 4:21 p.m.
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer - TipRanks

GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer TipRanks

Published: Dec. 16, 2024, 7:45 a.m.
EU recommends expanding use of GSK endometrial cancer drug - ShareCast

EU recommends expanding use of GSK endometrial cancer drug ShareCast

Published: Dec. 16, 2024, 7:35 a.m.
Hoy on cancer: I should have been thinking about it sooner - BBC.com

Hoy on cancer: I should have been thinking about it sooner BBC.com

Published: Dec. 14, 2024, 6:02 a.m.
Social Determinants of Health and Lifestyle Risk Factors Modulate Genetic Susceptibility for Women's Health Outcomes.

Women's health conditions are influenced by both genetic and environmental factors. Understanding these factors individually and their interactions is crucial for implementing preventative, personalized medicine. However, since genetics and environmental …

Published: Dec. 14, 2024, midnight
This Cancer Kills Thousands of Women Each Year, But Not Enough People Are Talking About It - Katie Couric Media

This Cancer Kills Thousands of Women Each Year, But Not Enough People Are Talking About It Katie Couric Media

Published: Dec. 13, 2024, 8:24 p.m.
Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Repare Therapeutics eyes Phase III cancer study after Mythic trial success Yahoo Finance

Published: Dec. 13, 2024, 3:28 p.m.
NSW mum diagnosed with stage four cancer two weeks after giving birth - MSN

NSW mum diagnosed with stage four cancer two weeks after giving birth MSN

Published: Dec. 13, 2024, 7:39 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!